Developer docs
API playgroundTry for free, no card

Search company profiles

Medifast

Full company profile

uuid000wh2t

Namestring
Medifast
Legal namestring
Medifast, Inc.
Websiteurl
medifastinc.com
Company typeenum
Public
Founded yearint
1981
Descriptiontext

Medifast, Inc. (NYSE: MED) is a publicly traded health and wellness company founded in 1981 and headquartered in Baltimore, Maryland. The company operates primarily through its OPTAVIA brand, a direct-to-consumer platform that sells meal replacement products (Fuelings), structured weight-management plans (notably the Optimal Weight 5 & 1 Plan), and coach-mediated behavioral support. Distribution is anchored by a network of approximately 14,000 independent OPTAVIA coaches who acquire clients, provide accountability, and drive product purchases; the OPTAVIA mobile app and website provide direct e-commerce access and integrate with Apple Health, Samsung Health, and Google Fit for biometric tracking.

The company's core intellectual property is the Habits of Health Transformational System, a proprietary methodology developed by co-founder Dr. Wayne Scott Andersen that addresses six dimensions of wellness (weight, eating/hydration, motion, sleep/energy, mind, surroundings) through incremental behavior changes called microHabits. Clinical evidence cited by the company includes randomized controlled trials showing 98% lean mass retention and 14% visceral fat reduction over 16 weeks. The product portfolio has expanded beyond core Fuelings into OPTAVIA ACTIVE (EAA Blend and Whey Protein, launched 2023), OPTAVIA ASCEND (high-protein mini-meals and nutrient packs targeted at GLP-1 medication users, launched 2024), and the Metabolic Synchronization framework introduced in late 2025.

Medifast generates revenue through subscription-like recurring purchases of OPTAVIA meal replacement products and plans, with coach productivity ($5,432 per active earning coach in Q1 2026, +19% YoY) serving as the primary operating metric. Revenue is concentrated in the United States and sold exclusively through the coach channel and direct-to-consumer e-commerce. As of February 2026, OPTAVIA became eligible for HSA/FSA reimbursement on select insurance plans, providing up to 40% pre-tax savings to clients and creating a new payment-access pathway. The company holds $168.9 million in cash with no debt as of Q1 2026 and is undergoing a strategic pivot from weight loss to metabolic health under incoming CEO Nicholas Johnson.

Short descriptiontext

Medifast (NYSE: MED) is a Baltimore-based health and wellness company that sells OPTAVIA meal replacement products, structured weight-management plans, and coach-guided metabolic health support through a network of approximately 14,000 independent coaches and direct-to-consumer e-commerce, serving U.S. health-conscious adults seeking weight management and metabolic health improvement.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersBaltimore, United States
HQ citystring
Baltimore
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
weight management products, meal replacement programs, metabolic health solutions, coach-guided wellness, nutritional supplements
Industry4 codes
1CRADAGAN
CodeCRADAGANPrimaryYes
2AFAKAJAF
CodeAFAKAJAFPrimaryNo
3HSADAFAB
CodeHSADAFABPrimaryNo
4AFAFAFAD
CodeAFAFAFADPrimaryNo
NAICS code2 codes
  • 812191
  • 311991
SIC code2 codes
  • 2000
  • 2090
Product category
Weight Management / Meal Replacement Products
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1OPTAVIA Program Products and Subscriptions
TypeSubscription Recurring
Description

Medifast generates revenue through the sale of OPTAVIA branded meal replacement products (Fuelings), plans, and coaching services. The business operates through a direct-to-consumer model with independent coaches as the primary distribution channel. Revenue per active earning coach serves as a key performance metric, having reached $5,432 per coach in Q1 2026, representing 19% year-over-year growth. The company maintains subscription-like revenue dynamics through recurring product purchases by coaching clients.

businesswire.com
2Coach Enablement and Support Services
TypeSubscription Recurring
Description

Revenue generated from independent OPTAVIA coaches who purchase products and services to support their client businesses. Coach productivity and retention directly impact revenue, with approximately 14,000 active earning coaches in Q1 2026.

businesswire.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Marketing or Sales, Operations, Personnel, Technology or R&D
Pricing details1 tier
1OPTAVIA Metabolic Health System - HSA/FSA Eligible
ModelSubscriptionBilling cadenceMonthly
Notes

Program eligible for HSA/FSA reimbursement on select insurance plans, allowing clients to use pre-tax medical funds for up to 40% savings on program costs.

stocktitan.net
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1OPTAVIA ACTIVE
Description

Product line scientifically designed to support muscle health and encourage healthy motion, including Essential Amino Acid (EAA) Blend and Whey Protein.

medifastinc.com
+5 more records
Core offering1 text field

Medifast manufactures and sells clinically developed meal replacement products (Fuelings) and structured weight management programs under its OPTAVIA brand. The company operates a coach-driven direct-to-consumer model combining proprietary meal replacements, the Habits of Health Transformational System, and independent coach support to deliver weight loss and metabolic health outcomes. Product lines include the Optimal Weight 5 & 1 Plan, OPTAVIA ACTIVE (amino acids and whey protein), and OPTAVIA ASCEND (mini meals for GLP-1 users).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 98% lean mass retained in clinical trial participants over 16 weeks
+5 more records
Product overview1 text field

Medifast is a health and wellness company operating primarily through its OPTAVIA brand, which offers a coach-driven metabolic health platform. The core offering consists of the Habits of Health Transformational System (a proprietary wellness methodology), the Optimal Weight 5 & 1 Plan (featuring Fuelings meal replacements and Lean & Green meals), and coach-guided support. The company has expanded its portfolio with OPTAVIA ACTIVE (EAA Blend and Whey Protein for muscle health, 2023) and OPTAVIA ASCEND (high-protein mini meals and nutrient packs for GLP-1 users, 2024), while pivoting toward Metabolic Synchronization as a holistic metabolic health approach. All products are backed by a Scientific Advisory Board and clinical research, distributed through a network of independent OPTAVIA Coaches.

Product and service7 records
1OPTAVIA Health and Wellness Program
CategoryCore weight management program
Description

The primary health and wellness brand offering scientifically developed products, clinically proven plans, and coach-guided support for achieving Lifelong Transformation through healthy habit development. Integrates four components: Coaches, Community, Plans/Products, and the Habits of Health Transformational System. For individual consumers seeking structured weight management and metabolic health support.

2Optimal Weight 5 & 1 Plan
CategoryMeal replacement weight loss plan
Description

The flagship meal replacement plan requiring five daily meal replacements (Fuelings) and one lean and green meal. Clinically proven for weight loss with results including 98% lean mass retained and 14% visceral fat reduction in clinical trials. For individual consumers seeking structured weight management.

3Fuelings Meal Replacements
CategoryNutritional meal replacement products
Description

Scientifically designed meal replacement products that serve as the nutritional foundation of OPTAVIA plans. Developed by physicians, dietitians and scientists to support healthy habit creation and weight management. For individual consumers enrolled in OPTAVIA plans.

4OPTAVIA ACTIVE
CategoryNutritional supplement product line
Description

Product line launched in 2023 including Essential Amino Acid (EAA) Blend and Whey Protein, scientifically designed to address muscle mass decline and support overall muscle health, encouraging the Habit of Healthy Motion. For individual consumers seeking muscle health support.

5OPTAVIA ASCEND
CategoryNutritional supplement product line
Description

Product line launched in 2024 featuring high-protein, fiber-rich mini meals and daily nutrient packs designed for people on GLP-1 medications and those seeking weight maintenance. Products promote muscle health, digestive health, and bone health. For GLP-1 medication users and consumers seeking weight maintenance.

6Metabolic Synchronization Program
CategoryMetabolic health program
Description

A strategic product approach introduced in late 2025 as part of Medifast's shift from weight loss to metabolic health. Targets visceral fat reduction, lean mass preservation, and muscle protection, offering benefits beyond traditional weight loss. For individual consumers seeking metabolic health improvement.

7OPTAVIA Premier
CategoryLoyalty and subscription program
Description

Auto-ship rewards program offering benefits, free gifts, and redeemable rewards for participants who enroll, including discounts for loyal customers. For individual consumers enrolled in OPTAVIA programs seeking savings and rewards.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Medifast's OPTAVIA platform includes collaboration with LifeMD for medical support services. This partnership enables clients to access medical guidance alongside the OPTAVIA coaching and nutrition program, providing a more comprehensive healthcare approach for weight management and metabolic health.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

WW is the most direct competitor to Medifast/OPTAVIA in the coach-supported weight management category, offering branded programs, community support, and food/recipe guidance. Both companies are publicly traded, US-focused, and similarly exposed to GLP-1-driven category disruption.

TypeDirect peer
Description

Jenny Craig historically offered center-based and direct-shipped meal replacement diet programs with one-on-one coaching — a direct predecessor business model to OPTAVIA, though the brand has significantly contracted.

TypeOthers
Description

Nestlé Health Science's Optifast is a globally distributed medically supervised meal-replacement program directly competing with OPTAVIA, with greater international reach and clinical backing as part of a much larger nutrition portfolio.

TypeDirect peer
Description

Noom is a digital psychology-based weight management platform with coach/guidance support via app, directly competing with OPTAVIA for the same health-conscious adult consumer seeking structured behavior change rather than just meal replacements.

TypeBroad incumbent
Description

Abbott's Ensure and similar medical/meal-replacement nutrition brands compete in the same clinical nutrition category as OPTAVIA Fuelings but with a much larger portfolio, broader distribution (retail, hospitals), and deeper healthcare channel access.

TypeOthers
Description

LifeMD is Medifast's telehealth partner providing medical support services to OPTAVIA clients — adjacent rather than competitive, but increasingly relevant as both companies pursue the GLP-1 patient population.

TypeDirect peer
Description

Herbalife operates a global direct-sales nutrition platform with meal-replacement shakes, protein products, and weight management programs distributed through independent distributors — a near-mirror of Medifast's OPTAVIA coach channel and Fuelings product model.

TypeDirect peer
Description

SlimFast is a heritage meal-replacement brand (shakes, bars, RTD products) competing with OPTAVIA Fuelings in the same CPG shelf-space and consumer use-case of portion-controlled weight management.

TypeDirect peer
Description

Nutrisystem sells portion-controlled meal plans and meal-replacement products direct-to-consumer, overlapping directly with the OPTAVIA 5 & 1 Plan offering for the same weight-management customer segment.

TypeBroad incumbent
Description

Glanbia's Optimum Nutrition and protein nutrition brands overlap with OPTAVIA ACTIVE (EAA blends, whey protein) in the sports and functional nutrition category, with much broader global CPG distribution.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medifast

Weight Management / Meal Replacement Productsmedifastinc.com

Medifast (NYSE: MED) is a Baltimore-based health and wellness company that sells OPTAVIA meal replacement products, structured weight-management plans, and coach-guided metabolic health support through a network of approximately 14,000 independent coaches and direct-to-consumer e-commerce, serving U.S. health-conscious adults seeking weight management and metabolic health improvement.

What Medifast does

Medifast, Inc. (NYSE: MED) is a publicly traded health and wellness company founded in 1981 and headquartered in Baltimore, Maryland. The company operates primarily through its OPTAVIA brand, a direct-to-consumer platform that sells meal replacement products (Fuelings), structured weight-management plans (notably the Optimal Weight 5 & 1 Plan), and coach-mediated behavioral support. Distribution is anchored by a network of approximately 14,000 independent OPTAVIA coaches who acquire clients, provide accountability, and drive product purchases; the OPTAVIA mobile app and website provide direct e-commerce access and integrate with Apple Health, Samsung Health, and Google Fit for biometric tracking.

The company's core intellectual property is the Habits of Health Transformational System, a proprietary methodology developed by co-founder Dr. Wayne Scott Andersen that addresses six dimensions of wellness (weight, eating/hydration, motion, sleep/energy, mind, surroundings) through incremental behavior changes called microHabits. Clinical evidence cited by the company includes randomized controlled trials showing 98% lean mass retention and 14% visceral fat reduction over 16 weeks. The product portfolio has expanded beyond core Fuelings into OPTAVIA ACTIVE (EAA Blend and Whey Protein, launched 2023), OPTAVIA ASCEND (high-protein mini-meals and nutrient packs targeted at GLP-1 medication users, launched 2024), and the Metabolic Synchronization framework introduced in late 2025.

Medifast generates revenue through subscription-like recurring purchases of OPTAVIA meal replacement products and plans, with coach productivity ($5,432 per active earning coach in Q1 2026, +19% YoY) serving as the primary operating metric. Revenue is concentrated in the United States and sold exclusively through the coach channel and direct-to-consumer e-commerce. As of February 2026, OPTAVIA became eligible for HSA/FSA reimbursement on select insurance plans, providing up to 40% pre-tax savings to clients and creating a new payment-access pathway. The company holds $168.9 million in cash with no debt as of Q1 2026 and is undergoing a strategic pivot from weight loss to metabolic health under incoming CEO Nicholas Johnson.

Medifast firmographics

Firmographics
Name
Medifast
Legal name
Medifast, Inc.
Website
https://medifastinc.com
Company type
Public
Founded year
1981
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Medifast (NYSE: MED) is a Baltimore-based health and wellness company that sells OPTAVIA meal replacement products, structured weight-management plans, and coach-guided metabolic health support through a network of approximately 14,000 independent coaches and direct-to-consumer e-commerce, serving U.S. health-conscious adults seeking weight management and metabolic health improvement.
Ownership category
akta.pro rank

Where Medifast is headquartered

Location

Headquarters

HQ city
Baltimore
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Medifast business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Marketing or Sales, Operations, Personnel, Technology or R&D

Revenue model

  1. OPTAVIA Program Products and Subscriptions: Medifast generates revenue through the sale of OPTAVIA branded meal replacement products (Fuelings), plans, and coaching services. The business operates through a direct-to-consumer model with independent coaches as the primary distribution channel. Revenue per active earning coach serves as a key performance metric, having reached $5,432 per coach in Q1 2026, representing 19% year-over-year growth. The company maintains subscription-like revenue dynamics through recurring product purchases by coaching clients.
  2. Coach Enablement and Support Services: Revenue generated from independent OPTAVIA coaches who purchase products and services to support their client businesses. Coach productivity and retention directly impact revenue, with approximately 14,000 active earning coaches in Q1 2026.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyOPTAVIA Metabolic Health System - HSA/FSA Eligible

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Medifast product offering

Product offering

Core offering

Medifast manufactures and sells clinically developed meal replacement products (Fuelings) and structured weight management programs under its OPTAVIA brand. The company operates a coach-driven direct-to-consumer model combining proprietary meal replacements, the Habits of Health Transformational System, and independent coach support to deliver weight loss and metabolic health outcomes. Product lines include the Optimal Weight 5 & 1 Plan, OPTAVIA ACTIVE (amino acids and whey protein), and OPTAVIA ASCEND (mini meals for GLP-1 users).

Product overview

Medifast is a health and wellness company operating primarily through its OPTAVIA brand, which offers a coach-driven metabolic health platform. The core offering consists of the Habits of Health Transformational System (a proprietary wellness methodology), the Optimal Weight 5 & 1 Plan (featuring Fuelings meal replacements and Lean & Green meals), and coach-guided support. The company has expanded its portfolio with OPTAVIA ACTIVE (EAA Blend and Whey Protein for muscle health, 2023) and OPTAVIA ASCEND (high-protein mini meals and nutrient packs for GLP-1 users, 2024), while pivoting toward Metabolic Synchronization as a holistic metabolic health approach. All products are backed by a Scientific Advisory Board and clinical research, distributed through a network of independent OPTAVIA Coaches.

Differentiator

Problem solved

Functional benefit

Brands

  • OPTAVIA ACTIVE: Product line scientifically designed to support muscle health and encourage healthy motion, including Essential Amino Acid (EAA) Blend and Whey Protein.
  • OPTAVIA ASCEND
  • OPTAVIA Premier
  • OPTAVIA CONNECT
  • Habits of Health Transformational System
  • Metabolic Synchronization

Products and services

  • OPTAVIA Health and Wellness Program The primary health and wellness brand offering scientifically developed products, clinically proven plans, and coach-guided support for achieving Lifelong Transformation through healthy habit development. Integrates four components: Coaches, Community, Plans/Products, and the Habits of Health Transformational System. For individual consumers seeking structured weight management and metabolic health support.
  • Optimal Weight 5 & 1 Plan The flagship meal replacement plan requiring five daily meal replacements (Fuelings) and one lean and green meal. Clinically proven for weight loss with results including 98% lean mass retained and 14% visceral fat reduction in clinical trials. For individual consumers seeking structured weight management.
  • Fuelings Meal Replacements Scientifically designed meal replacement products that serve as the nutritional foundation of OPTAVIA plans. Developed by physicians, dietitians and scientists to support healthy habit creation and weight management. For individual consumers enrolled in OPTAVIA plans.
  • OPTAVIA ACTIVE Product line launched in 2023 including Essential Amino Acid (EAA) Blend and Whey Protein, scientifically designed to address muscle mass decline and support overall muscle health, encouraging the Habit of Healthy Motion. For individual consumers seeking muscle health support.
  • OPTAVIA ASCEND Product line launched in 2024 featuring high-protein, fiber-rich mini meals and daily nutrient packs designed for people on GLP-1 medications and those seeking weight maintenance. Products promote muscle health, digestive health, and bone health. For GLP-1 medication users and consumers seeking weight maintenance.
  • Metabolic Synchronization Program A strategic product approach introduced in late 2025 as part of Medifast's shift from weight loss to metabolic health. Targets visceral fat reduction, lean mass preservation, and muscle protection, offering benefits beyond traditional weight loss. For individual consumers seeking metabolic health improvement.
  • OPTAVIA Premier Auto-ship rewards program offering benefits, free gifts, and redeemable rewards for participants who enroll, including discounts for loyal customers. For individual consumers enrolled in OPTAVIA programs seeking savings and rewards.

Quantifiable outcome

  • 98% lean mass retained in clinical trial participants over 16 weeks
  • +5 more outcomes

Companies that use Medifast

Customer profile

Segments3 records

Ideal customer profiles3 records

Medifast technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

Feature4 records

Medifast partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • LifeMDcoreStrategic or Co-development PartnerMedifast's OPTAVIA platform includes collaboration with LifeMD for medical support services. This partnership enables clients to access medical guidance alongside the OPTAVIA coaching and nutrition program, providing a more comprehensive healthcare approach for weight management and metabolic health.

Scale indicators9 records

Recent moves8 records

Expansion highlights6 records

Medifast competitors and assessment

Company assessment

Direct peers

  • WW International (Weight Watchers): WW is the most direct competitor to Medifast/OPTAVIA in the coach-supported weight management category, offering branded programs, community support, and food/recipe guidance. Both companies are publicly traded, US-focused, and similarly exposed to GLP-1-driven category disruption.
  • Jenny Craig: Jenny Craig historically offered center-based and direct-shipped meal replacement diet programs with one-on-one coaching — a direct predecessor business model to OPTAVIA, though the brand has significantly contracted.
  • Noom: Noom is a digital psychology-based weight management platform with coach/guidance support via app, directly competing with OPTAVIA for the same health-conscious adult consumer seeking structured behavior change rather than just meal replacements.
  • Herbalife: Herbalife operates a global direct-sales nutrition platform with meal-replacement shakes, protein products, and weight management programs distributed through independent distributors — a near-mirror of Medifast's OPTAVIA coach channel and Fuelings product model.
  • SlimFast: SlimFast is a heritage meal-replacement brand (shakes, bars, RTD products) competing with OPTAVIA Fuelings in the same CPG shelf-space and consumer use-case of portion-controlled weight management.
  • Nutrisystem: Nutrisystem sells portion-controlled meal plans and meal-replacement products direct-to-consumer, overlapping directly with the OPTAVIA 5 & 1 Plan offering for the same weight-management customer segment.

Others

  • Nestlé Health Science (Optifast): Nestlé Health Science's Optifast is a globally distributed medically supervised meal-replacement program directly competing with OPTAVIA, with greater international reach and clinical backing as part of a much larger nutrition portfolio.
  • LifeMD: LifeMD is Medifast's telehealth partner providing medical support services to OPTAVIA clients — adjacent rather than competitive, but increasingly relevant as both companies pursue the GLP-1 patient population.

Broad incumbents

  • Abbott Nutrition: Abbott's Ensure and similar medical/meal-replacement nutrition brands compete in the same clinical nutrition category as OPTAVIA Fuelings but with a much larger portfolio, broader distribution (retail, hospitals), and deeper healthcare channel access.
  • Glanbia / Optimum Nutrition: Glanbia's Optimum Nutrition and protein nutrition brands overlap with OPTAVIA ACTIVE (EAA blends, whey protein) in the sports and functional nutrition category, with much broader global CPG distribution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Medifast social profiles

Digital presence

Medifast compliance and trust

Trust signal

Compliance3 records

Medifast financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medifast leadership team

Management profile

Number of profiles

Profiles4 records

Medifast subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Medifast funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medifast M&A and investment

M&A and investment

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medifast

What does Medifast do?

Medifast manufactures and sells clinically developed meal replacement products (Fuelings) and structured weight management programs under its OPTAVIA brand. The company operates a coach-driven direct-to-consumer model combining proprietary meal replacements, the Habits of Health Transformational System, and independent coach support to deliver weight loss and metabolic health outcomes. Product lines include the Optimal Weight 5 & 1 Plan, OPTAVIA ACTIVE (amino acids and whey protein), and OPTAVIA ASCEND (mini meals for GLP-1 users).

Is Medifast a public or private company?

Medifast is a public company. It is classified as public and is currently operating.

When was Medifast founded?

Medifast was founded in 1981. It employs 501 to 1,000 people.

Where is Medifast based?

Medifast is headquartered in Baltimore, United States, in the North America region.

How does Medifast make money?

Two revenue lines are on record. OPTAVIA Program Products and Subscriptions are the primary driver. The others are coach Enablement and Support Services.

Who are Medifast's main competitors?

Direct peers on record are WW International (Weight Watchers), Jenny Craig, Noom, Herbalife, SlimFast and Nutrisystem. Others are Nestlé Health Science (Optifast) and LifeMD. Broad incumbents are Abbott Nutrition and Glanbia / Optimum Nutrition.

Does Medifast have an API?

No public API is recorded for Medifast.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Quiver QuantitativeMedifast’s Trilivy Highlights Five Factors That Drive Weight Regain and Its Metabolic Synchronization Framework | MED Stock NewsMedifast's Trilivy system addresses weight regain by targeting five factors: slowed metabolism, hormonal changes, lack of support, set point theory, and metabolic adaptation. Its Reset 5 & 1 Plan reported 98% lean mass retention and a 14% visceral fat reduction at 16 weeks. The company also introduced Metabolic Synchronization® to preserve lean mass and reduce visceral fat.Defense WorldBank of America Corp DE Purchases New Holdings in Medifast Inc $MEDBank of America Corp DE acquired a new stake in Medifast, purchasing 87,118 shares worth about $924,000 in Q2. The bank now holds 0.78% of the company, while insiders own 3.70% and hedge funds hold 95.51%. Analysts have a consensus price target of $12.00.American Banking and Market NewsBank of America Corp DE Makes New Investment in Medifast Inc $MEDBank of America Corp DE acquired a new stake in Medifast during Q2, buying 87,118 shares valued at about $924,000. Medifast reported Q2 EPS of -$0.28, beating the -$0.65 consensus, with revenue of $76.38 million. Analysts have a consensus target price of $12.00.YahooQ2 Earnings Roundup: Medifast (NYSE:MED) And The Rest Of The Personal Care SegmentFive personal care stocks reported Q2 results, with revenues beating consensus by 1.7% and guidance up 1.5%. Medifast saw revenue fall 27.6% year on year, while e.l.f. Beauty rose 35.5%. The group's average stock price dropped 7.2% since earnings.The future of tradingMedifast Director Daniel R. Chard disposes of USD 226,048 in common sharesMedifast director Daniel R. Chard sold 19,089 common shares on Sept. 28-29, 2026, at weighted-average prices of $11.9788 and $11.73, totaling $226,048. The Dan and Allyson Family Irrevocable Trust held 130,609 shares after the transactions.YahooIs Laird Superfood (LSF) Stock Outpacing Its Consumer Staples Peers This Year?Laird Superfood, Inc. has gained about 70.7% year-to-date, outperforming the Consumer Staples sector's average gain of 8.2%. The company holds a Zacks Rank of #2 (Buy) with consensus EPS estimates up 18.2% in the past quarter. Medifast also outperformed the sector with a 12% YTD gain.Ticker ReportComparing USANA Health Sciences (NYSE:USNA) & Medifast (NYSE:MED)Medifast and USANA Health Sciences are compared on financial metrics, with Medifast beating on 7 of 13 factors. USANA has higher revenue and earnings but a lower price-to-earnings ratio, while Medifast has stronger analyst ratings and a consensus target price of $12.00.Defense WorldEmpowered Funds LLC Takes $701,000 Position in Medifast Inc $MEDEmpowered Funds LLC bought 66,105 Medifast shares worth about $701,000 in Q2, giving it a 0.59% stake. Analysts rate the stock a consensus "Reduce" with a $12 target, and Medifast reported Q2 EPS of -$0.28, beating estimates.Yahoo3 Cash-Producing Stocks That Concern UsMedifast, Viatris, and Insperity are highlighted as cash-producing stocks to avoid due to poor cash allocation. Medifast's revenue fell 38.7% annually over three years, Viatris' revenue declined 1.7% annually, and Insperity's sales growth of 2.5% lagged typical business services.Ticker ReportMedifast (NYSE:MED) and Waldencast (NASDAQ:WALDW) Financial ReviewA MarketBeat comparison reviewed Waldencast and Medifast across institutional ownership, earnings, valuation, profitability and analyst recommendations. Medifast showed 95.5% institutional ownership, $385.79 million revenue, -$2.33 per share earnings and a $12.00 consensus target, while Waldencast had no ratings or financial data. Medifast beat Waldencast on five of eight factors.